Key result
This article reviews the incidence, pathophysiology, diagnostic criteria, and treatment considerations for arrhythmogenic right ventricular cardiomyopathy.
Why the study?
ARVC has highly variable clinical course and genetics making definitive diagnosis challenging, while a safe exercise regimen remains uncertain.
This review summarizes the incidence, pathophysiology, diagnostic criteria, and treatment considerations for arrhythmogenic right ventricular cardiomyopathy, highlighting the importance of personalized management and exercise regimens.
Answers are grounded in this paper and cite their sources.
May inform personalized ARVC management with exercise focus; leaves open prospective trials on optimal regimens.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited cardiac disease characterized by fibrofatty replacement of myocardial tissue and is an important cause of ventricular dysrhythmias, ventricular dysfunction, and sudden cardiac death. The clinical course and genetics of this condition are highly variable, and definitive diagnosis can be challenging, despite published diagnostic criteria. Recognizing symptoms and risk factors for ventricular dysrhythmias is key to managing affected patients and family members. High-intensity and endurance exercise is widely known to increase disease expression and progression; however, a safe exercise regimen remains uncertain, and a personalized approach to management should be considered. This article reviews the incidence, pathophysiology, diagnostic criteria, and treatment considerations for ARVC.
No takes yet. Share an insight, caveat, or question.
Regina Welkie (2023) conducted a review in Arrhythmogenic right ventricular cardiomyopathy. This article reviews the incidence, pathophysiology, diagnostic criteria, and treatment considerations for arrhythmogenic right ventricular cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: